Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Crew

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
European Urology|February 6, 1999
Vascular endothelial growth factor: an important angiogenic mediator in bladder cancerJ P Crew
British Journal of Urology|May 1, 1997
Management of superficial bladder cancerJ P Crew, D Cranston
BJU International|April 22, 1999
p53 and p53-regulated genes in bladder cancerJ P Crew, A Jones
British Journal of Urology|June 1, 1996
Epidural needle and catheter for bladder instillation of a marker dyeJ P Crew, G J Fellows
Anticancer Research|March 23, 2002
Angiogenesis, angiogenic factor expression and prognosis of bladder cancerE H Streeter, J P Crew
Scandinavian Journal of Urology and Nephrology|June 1, 1996
Symptomatic urethral hair ball and diverticulum complicating island flap urethroplastyJ P Crew, V Nargund, G J Fellows
Drug Safety|July 23, 1998
Drug-induced bladder and urinary disorders. Incidence, prevention and managementM J Drake, P M Nixon, J P Crew
European Urology|August 31, 2001
Radiation-induced haemorrhagic cystitisJ P Crew, C R Jephcott, J M Reynard
Cancer Metastasis Reviews|June 1, 1996
Bladder cancer angiogenesis, its role in recurrence, stage progression and as a therapeutic targetJ P Crew, T S O'Brien, A L Harris
The British Journal of Clinical Practice|January 1, 1997
Bilateral ureteric obstruction secondary to the prolonged use of tiaprofenic acidJ P Crew, R Donat, D Roskell, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
European Urology|February 6, 1999
Vascular endothelial growth factor: an important angiogenic mediator in bladder cancerJ P Crew
British Journal of Urology|May 1, 1997
Management of superficial bladder cancerJ P Crew, D Cranston
BJU International|April 22, 1999
p53 and p53-regulated genes in bladder cancerJ P Crew, A Jones
British Journal of Urology|June 1, 1996
Epidural needle and catheter for bladder instillation of a marker dyeJ P Crew, G J Fellows
Anticancer Research|March 23, 2002
Angiogenesis, angiogenic factor expression and prognosis of bladder cancerE H Streeter, J P Crew
Scandinavian Journal of Urology and Nephrology|June 1, 1996
Symptomatic urethral hair ball and diverticulum complicating island flap urethroplastyJ P Crew, V Nargund, G J Fellows
Drug Safety|July 23, 1998
Drug-induced bladder and urinary disorders. Incidence, prevention and managementM J Drake, P M Nixon, J P Crew
European Urology|August 31, 2001
Radiation-induced haemorrhagic cystitisJ P Crew, C R Jephcott, J M Reynard
Cancer Metastasis Reviews|June 1, 1996
Bladder cancer angiogenesis, its role in recurrence, stage progression and as a therapeutic targetJ P Crew, T S O'Brien, A L Harris
The British Journal of Clinical Practice|January 1, 1997
Bilateral ureteric obstruction secondary to the prolonged use of tiaprofenic acidJ P Crew, R Donat, D Roskell, et al.
Pageof 2